253 related articles for article (PubMed ID: 25388280)
21. Health-related quality of life in patients with primary biliary cholangitis: a cross-sectional study from a single centre in Denmark.
Skat-Rørdam PA; Eliasson J; Skalshøi Kjær M; Bekker Jeppesen P; Ytting H
Minerva Gastroenterol (Torino); 2023 Jun; ():. PubMed ID: 37326627
[TBL] [Abstract][Full Text] [Related]
22. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634].
ter Borg PC; van Os E; van den Broek WW; Hansen BE; van Buuren HR
BMC Gastroenterol; 2004 Jul; 4():13. PubMed ID: 15251034
[TBL] [Abstract][Full Text] [Related]
23. TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.
Raszeja-Wyszomirska J; Wunsch E; Kempinska-Podhorodecka A; Smyk DS; Bogdanos DP; Milkiewicz M; Milkiewicz P
Clin Dev Immunol; 2013; 2013():510547. PubMed ID: 23710202
[TBL] [Abstract][Full Text] [Related]
24. Symptoms and health-related quality of life in Japanese patients with primary biliary cholangitis.
Yagi M; Tanaka A; Abe M; Namisaki T; Yoshiji H; Takahashi A; Ohira H; Komori A; Yamagiwa S; Kikuchi K; Yasunaka T; Takaki A; Ueno Y; Honda A; Matsuzaki Y; Takikawa H
Sci Rep; 2018 Aug; 8(1):12542. PubMed ID: 30135523
[TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in Chinese patients with primary biliary cirrhosis.
Wong GL; Law FM; Wong VW; Hui AY; Chan FK; Sung JJ; Chan HL
J Gastroenterol Hepatol; 2008 Apr; 23(4):592-8. PubMed ID: 17645470
[TBL] [Abstract][Full Text] [Related]
26. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
[TBL] [Abstract][Full Text] [Related]
27. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease.
Silveira MG; Mendes FD; Diehl NN; Enders FT; Lindor KD
Liver Int; 2009 Aug; 29(7):1094-100. PubMed ID: 19291181
[TBL] [Abstract][Full Text] [Related]
28. Dehydroepiandrosterone sulfate indicates decreased sulfation capacity and impaired quality of life in patients with primary sclerosing cholangitis.
Wronka KM; Wunsch E; Kozłowska-Petriczko K; Wójcicki M; Kruk B; Milkiewicz P
Pol Arch Intern Med; 2021 Sep; 131(9):790-796. PubMed ID: 34132084
[TBL] [Abstract][Full Text] [Related]
29. Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis.
Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kalaitzakis E
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):769-775.e2. PubMed ID: 22343690
[TBL] [Abstract][Full Text] [Related]
30. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis.
Jacoby A; Rannard A; Buck D; Bhala N; Newton JL; James OF; Jones DE
Gut; 2005 Nov; 54(11):1622-9. PubMed ID: 15961522
[TBL] [Abstract][Full Text] [Related]
31. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Franco J; Saeian K
Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
34. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
35. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study.
Carbone M; Bufton S; Monaco A; Griffiths L; Jones DE; Neuberger JM
J Hepatol; 2013 Sep; 59(3):490-4. PubMed ID: 23628322
[TBL] [Abstract][Full Text] [Related]
36. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
Bressler B; Pinto R; El-Ashry D; Heathcote EJ
Gut; 2005 Mar; 54(3):407-10. PubMed ID: 15710991
[TBL] [Abstract][Full Text] [Related]
37. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
[TBL] [Abstract][Full Text] [Related]
38. Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis.
Larson L; James M; Gossard A
AACN Adv Crit Care; 2016 Oct; 27(4):441-452. PubMed ID: 27959300
[TBL] [Abstract][Full Text] [Related]
39. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
Fejfar T; Vaňásek T; Hůlek P
Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO.
Younossi ZM; Afendy A; Stepanova M; Racila A; Nader F; Gomel R; Safer R; Lenderking WR; Skalicky A; Kleinman L; Myers RP; Subramanian GM; McHutchison JG; Levy C; Bowlus CL; Kowdley K; Muir AJ
Hepatology; 2018 Jul; 68(1):155-165. PubMed ID: 29152767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
